Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Eluxadoline
Therapeutic Area : Gastroenterology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Eluxadoline is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Irritable Bowel Syndrome.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 11, 2021
Lead Product(s) : Eluxadoline
Therapeutic Area : Gastroenterology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Eluxadoline
Therapeutic Area : Gastroenterology
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Zydus Receives Final Approval from USFDA for Eluxadoline Tablets, 75 mg and 100 mg
Details : Viberzi-Generic (eluxadoline) is a mu-opioid receptor agonist, indicated in adults for the treatment of irritable bowel syndrome with diarrhea.
Product Name : Viberzi-Generic
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 17, 2025
Lead Product(s) : Eluxadoline
Therapeutic Area : Gastroenterology
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Eluxadoline
Therapeutic Area : Gastroenterology
Study Phase : Phase II/ Phase III
Sponsor : Allergan
Deal Size : Inapplicable
Deal Type : Inapplicable
Investigation of Eluxadoline for Diabetic Diarrhea
Details : Eluxadoline is a Other Small Molecule drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Diabetic Diarrhea.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 18, 2020
Lead Product(s) : Eluxadoline
Therapeutic Area : Gastroenterology
Highest Development Status : Phase II/ Phase III
Sponsor : Allergan
Deal Size : Inapplicable
Deal Type : Inapplicable